Literature DB >> 24590268

Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.

Jihua Yang1, Shunchang Jiao.   

Abstract

The rs2736100 polymorphism in the telomerase reverse transcriptase (TERT) gene has been implicated in lung cancer risk in multiple populations, but the existing evidence lacks statistical power to draw a convincing conclusion. Therefore, the present study was devised to derive a more precise estimation of the association between rs2736100 and lung cancer risk. The PubMed, Embase, and Web of Science databases were comprehensively searched for papers concerning lung cancer risk in relation to rs2736100. Pooled odds ratios (ORs) and the 95 % confidence intervals (CIs) were appropriately calculated using the fixed or random effects model. Meta-analysis of 20 independent studies involving 39,715 cancer cases and 61,462 control subjects showed statistical evidence for an association between rs2736100 and increased risk of lung cancer. Subgroup analysis by ethnicity demonstrated a significant association among both Asian and Caucasian populations. We additionally found an increased risk of non-small cell lung cancer and lung adenocarcinoma strongly associated with rs2736100. These data provide further evidence supporting a role for genetic susceptibility of TERT rs2736100 in the development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590268     DOI: 10.1007/s13277-014-1765-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.

Authors:  Daiki Miki; Michiaki Kubo; Atsushi Takahashi; Kyong-Ah Yoon; Jeongseon Kim; Geon Kook Lee; Jae Ill Zo; Jin Soo Lee; Naoya Hosono; Takashi Morizono; Tatsuhiko Tsunoda; Naoyuki Kamatani; Kazuaki Chayama; Takashi Takahashi; Johji Inazawa; Yusuke Nakamura; Yataro Daigo
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

3.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter.

Authors:  Y S Cong; J Wen; S Bacchetti
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

4.  Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Patrick T Bradshaw; Qiao Wang; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Breast Cancer Res Treat       Date:  2012-04-12       Impact factor: 4.872

Review 5.  TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.

Authors:  Hui-Min Wang; Xue-Yan Zhang; Bo Jin
Journal:  Genet Test Mol Biomarkers       Date:  2013-12

6.  Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.

Authors:  Darren R Brenner; Paul Brennan; Paolo Boffetta; Christopher I Amos; Margaret R Spitz; Chu Chen; Gary Goodman; Joachim Heinrich; Heike Bickeböller; Albert Rosenberger; Angela Risch; Thomas Muley; John R McLaughlin; Simone Benhamou; Christine Bouchardy; Juan Pablo Lewinger; John S Witte; Gary Chen; Shelley Bull; Rayjean J Hung
Journal:  Hum Genet       Date:  2013-02-01       Impact factor: 4.132

7.  Lifetime risks of common cancers among retinoblastoma survivors.

Authors:  Olivia Fletcher; Douglas Easton; Kristin Anderson; Clare Gilham; Marcelle Jay; Julian Peto
Journal:  J Natl Cancer Inst       Date:  2004-03-03       Impact factor: 13.506

8.  Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population.

Authors:  Guangfu Jin; Lin Xu; Yongqian Shu; Tian Tian; Jie Liang; Yan Xu; Furu Wang; Jianjian Chen; Juncheng Dai; Zhibin Hu; Hongbing Shen
Journal:  Carcinogenesis       Date:  2009-04-15       Impact factor: 4.944

9.  Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population.

Authors:  Zhenhong Zhao; Cong Li; Lixin Yang; Xiaobo Zhang; Xueying Zhao; Xiao Song; Xiaoying Li; Jiucun Wang; Ji Qian; Yajun Yang; Li Jin; Hongyan Chen; Daru Lu
Journal:  Exp Lung Res       Date:  2013-01-31       Impact factor: 2.459

Review 10.  Systematic review of the relationship between family history and lung cancer risk.

Authors:  A Matakidou; T Eisen; R S Houlston
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

View more
  7 in total

1.  Sal-like protein 2 upregulates p16 expression through a proximal promoter element.

Authors:  Zhenghua Wu; Kebin Cheng; Lidan Shi; Zheqi Li; Hema Negi; Guangwei Gao; Suchitra Kamle; Dawei Li
Journal:  Cancer Sci       Date:  2015-03-03       Impact factor: 6.716

2.  Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.

Authors:  Xu Wang; Kewei Ma; Lumei Chi; Jiuwei Cui; Lina Jin; Ji-Fan Hu; Wei Li
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

3.  Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

Authors:  Mohamed Ali Mosrati; Kerstin Willander; Ingrid Jakobsen Falk; Monica Hermanson; Martin Höglund; Dick Stockelberg; Yuan Wei; Kourosh Lotfi; Peter Söderkvist
Journal:  Oncotarget       Date:  2015-09-22

4.  The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis.

Authors:  Hui Li; Yanyan Xu; Hua Mei; Liang Peng; Xiaojie Li; Jianzhou Tang
Journal:  Oncotarget       Date:  2017-06-13

5.  Do Polymorphisms of the TERT, GSTM1, and GSTT1 Genes Increase Laryngeal Cancer Susceptibility in Smokers of Romanian Descent?

Authors:  Corina Iulia Cornean; Andreea Catana; Alma Aurelia Maniu
Journal:  Medicina (Kaunas)       Date:  2022-08-16       Impact factor: 2.948

6.  TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.

Authors:  Mohamed Ali Mosrati; Annika Malmström; Malgorzata Lysiak; Adam Krysztofiak; Martin Hallbeck; Peter Milos; Anna-Lotta Hallbeck; Charlotte Bratthäll; Michael Strandéus; Marie Stenmark-Askmalm; Peter Söderkvist
Journal:  Oncotarget       Date:  2015-06-30

Review 7.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.